A carregar...
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
BACKGROUND: Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. OBJECTIV...
Na minha lista:
| Publicado no: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178718/ https://ncbi.nlm.nih.gov/pubmed/30349888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12142 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|